Cost advantages of combination asthma therapy

Treatments in Respiratory Medicine
Debbie A Campbell, Douglas S Robinson

Abstract

The addition of long-acting beta(2)-adrenoceptor agonist (LABA) therapy to 'low dose' inhaled corticosteroids improves asthma outcomes in terms of lung function, exacerbation rates, and quality of life measures in asthmatic patients who remain symptomatic on low-dose inhaled corticosteroids alone. Such treatment is now included in guidelines of asthma therapy on the basis of class A evidence from large placebo-controlled trials. Data on the cost-benefit of such treatment is less compelling, but suggests that for patients with mild asthma this clinical improvement is gained at the expense of an increase in direct costs (mostly drug costs), whereas for patients with more severe asthma there may be a cost benefit, largely from reduced costs of exacerbations. Recently, combination inhalers containing both LABA and corticosteroid in the same device have been introduced. Although it is said that a single inhaler (with some immediate symptom relief) may aid patient adherence, there are no firm data to support this, nor are there any cost-effectiveness data on this point. Overall, these devices have been priced at less than the two drugs given separately, but prospective studies evaluating costs in clinical settings are required.

References

Mar 26, 1992·The New England Journal of Medicine·K B WeissT A Hodgson
Jun 15, 1992·The Medical Journal of Australia·A BaumanS R Leeder
Apr 1, 1994·International Journal of Epidemiology·M L BurrF Nagel
May 1, 1996·American Journal of Respiratory and Critical Care Medicine·A WoolcockL A Jacques
Apr 1, 1996·The European Respiratory Journal·P J BarnesJ B Klim
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·D H SmithW B Saunders
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·G ShapiroT Shah
Jun 26, 2001·Respiratory Medicine·F AnderssonUNKNOWN Formoterol and Corticosteroid Establishing Therapy. International Study Group

❮ Previous
Next ❯

Citations

Feb 10, 2007·Current Medical Research and Opinion·Howard S Friedman, Barbara P Yawn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.